1Morrow D A, de Lemos J A, Sabatine M S, et al. The search for a biomarker of cardiac ischemia [ J ]. Clin Chem, 2003,49 ( 4 ): 537-539.
2Peters T. All about albumin: biochemistry, genetics and medical applications[ M]. San Diego:Academic Press,1996,79-126.
3Chan B, Dodsworth N. Woodrow J, et al. Site-specific N-terminal auto degradation of human serum albumin [ J ]. Eur J Biochem, 1995,277(1-2) :524-528.
4Bar-Or D, Lau E, Rao N, et al. Reduction in cobalt binding capacity of human albumin with myocardial ischemia [ J ]. Ann Emerg Med, 1999,34 (4Suppl): S56 (Abstract).
5Bernshtein E, Mayer B, Goldberg C, et al. Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury [ J ]. J Mol Cell Cardiol, 1997,29 ( 11 ): 3025 -3034.
6Wu A H B, Morris D L, Fletcher D R, et al. Analysis of the albumin cobalt binding ( ACBTM ) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction [ J ]. Cardiovascular Toxicology, 2001,1 ( 2 ): 147-151.
7deFilippi C, Yoon S, Ro A, et al. Early detection of myocardial ischemia by a novel blood based biomarker: The kinetics of ischemia modified albumin[ J ]. JACC ,2003,41: ( 6Supp1 A) :340A.
8Bar-Or D, Winkier J, VanBenthuysen K, et al. Reduced cobalt binding of human albumin with transient myocardial ischemia following elective percutaneous transluminal coronary angioplasty compared to CK-MB,myoglobin and troponin [ J ]. Am Heart J, 2001,141 ( 6 ):985-991.
9Sinha M K, Gaze D C, Tippins J R, et al. Ischemia modified albumin is asensitive marker of myocardial ischemia after percutaneous coronary intervention[ J]. Circulation,2003,107 (19) :2403-2405.
10ACB Test Reagent Pack, COBAS MTRA Plus. Package insert,August 200.
